An easy-to-use dry-powder inhaler

被引：11
|
作者：
Karpel, JP [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA
来源：
ADVANCES IN THERAPY | 2000年 / 17卷 / 06期
关键词：
asthma; corticosteroid; inhalation therapy; dry-powder inhaler; mometasone furoate; compliance;
D O I：
10.1007/BF02850011
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The mometasone furoate dry-powder inhaler is a novel device designed to support compliance by delivering a topical corticosteroid in a simple three-step operation. This breath-actuated inhaler uses a stabilized agglomerate formulation to measure and deliver accurate, uniform, and precise doses of drug over a range of inspiratory flow rates. Laboratory and clinical data have shown that the design produced a simple, clinically effective inhaler for the treatment of adults and children 12 years of age and older with mild, moderate, or severe persistent asthma.
引用
收藏
页码：282 / 286
页数：5
相关论文
共 50 条
  • [1] An easy-to-use dry-powder inhaler
    Jill P. Karpel
    Advances in Therapy, 2000, 17 : 282 - 286
  • [2] Patient handling of a dry-powder inhaler in clinical practice
    Epstein, S
    Maidenberg, A
    Hallett, D
    Khan, K
    Chapman, KR
    CHEST, 2001, 120 (05) : 1480 - 1484
  • [3] Fluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EU
    Deeks E.D.
    Lyseng-Williamson K.A.
    Syed Y.Y.
    Drugs & Therapy Perspectives, 2017, 33 (4) : 153 - 159
  • [4] Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative Review of the Evidence
    Federico Lavorini
    Jerzy Chudek
    Gabriella Gálffy
    Abel Pallarés-Sanmartin
    Anna S. Pelkonen
    Paula Rytilä
    Jörgen Syk
    Maria Szilasi
    Lilla Tamási
    Athanasios Xanthopoulos
    Tari Haahtela
    Pulmonary Therapy, 2021, 7 : 409 - 427
  • [5] Mometasone furoate dry-powder inhaler for the control of persistent asthma
    D'Urzo, Anthony
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (16) : 2871 - 2884
  • [6] Systemic Delivery of Atropine Sulfate by the MicroDose Dry-Powder Inhaler
    Corcoran, T. E.
    Venkataramanan, R.
    Hoffman, R. M.
    George, M. P.
    Petrov, A.
    Richards, T.
    Zhang, S.
    Choi, J.
    Gao, Y. Y.
    Oakum, C. D.
    Cook, R. O.
    Donahoe, M.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (01) : 46 - 55
  • [7] Implementation of a Metered-Dose Inhaler to Dry-Powder Inhaler National Formulary Transition
    Rabin, Alexander S.
    Weinstein, Julien B.
    Whittington, Taylor N.
    Hogan, Cainnear K.
    Khachikian, Deborah
    Seelye, Sarah M.
    Prescott, Hallie C.
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [8] Fluticasone furoate/umeclidinium/vilanterol dry-powder inhaler in COPD: a profile of its use in the EU
    Syed Y.Y.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2018, 34 (6) : 241 - 247
  • [9] Relationship between the ability to learn dry-powder inhaler use and the cognitive functions in patients with COPD
    Tulek, Baykal
    Atalay, Nart Bedin
    Kurtipek, Ercan
    Yildirim, Gulfem
    Kanat, Fikret
    Suerdem, Mecit
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Dry-powder inhaler use in primary school-aged children with asthma: a systematic review
    Kuek, Stephanie L.
    Wong, Nicole X.
    Dalziel, Stuart
    Hatter, Lee
    Fleming, Louise
    Bush, Andrew
    Beasley, Richard
    Shanthikumar, Shivanthan
    ERJ OPEN RESEARCH, 2024, 10 (06)
12345